In this report we further study the Cd2ap+/-, Fyn-/- bigenic murine model of FSGS, examining gene expression changes that take place in the glomerular podocyte, mesangial and endothelial cells. The gene discussed is FYN; the disease is focal segmental glomerulosclerosis.